Jaguar Health, Inc. (JAGX) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $0.24, down from yesterday’s close by -9.32%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.Fundamental Analysis
Jaguar Health, Inc. (JAGX) currently trades with a market capitalization of $35.19 Million. That value represents a market adjusting for revenues that have been growing by 2,084.69 % on a quarterly year/year basis as of the company’s last quarterly report.
You can get a sense of how sustainable that is by a levered free cash flow of $0 over the past twelve months. Generally speaking, earnings are expected to hold steady in coming quarters. Analysts are forecasting earnings of $0 on a per share basis this quarter. Perhaps, that suggests something about why 0.00% of the outstanding share supply is held by institutional investors.
Sometimes, we can understand most about a stock by simply looking at how it has been trading. Looking at the stock’s movement on the chart, Jaguar Health, Inc. recorded a 52-week high of $1.30. It is now trading 1.06% off that level. The stock is trading $0.15 its 50-day moving average by -0.09%. The stock carved out a 52-week low down at $0.10.
In recent action, Jaguar Health, Inc. (JAGX) has made a move of +71.43% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 16.68, and it’s gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 8.83% with $56.88 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of JAGX.